Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pandion Therapeutics, Inc. (PAND)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19
   10-K10-K
Cash flows from operating activities    
Net loss  -38.1-21.9
   
Adjustment to reconcile net loss to net cash used in operating activities:    
    Depreciation expense  0.50.2
    Equity-based compensation expense  2.60.1
    Fair value adjustments on convertible notes  -0.1-0.1
    Noncash interest expense  0.20.0
    (Gain) loss on disposal of property and equipment  0.00.0
    Changes in operating assets and liabilities:    
        Accounts receivable  0.1-1.0
        Prepaid expenses and other current assets  -0.1-1.7
        Accounts payable  0.50.4
        Accrued expenses and other current liabilities  1.70.1
        Deferred rent  0.5 
        Deferred revenue  -2.910.4
            Net cash used in operating activities  -35.0-13.4
   
Cash flows from investing activities    
Purchases of property and equipment  -2.8-0.6
    Net cash used in investing activities  -2.8-0.6
   
Cash flows from financing activities    
Proceeds from simple agreement for future equity  6.0 
Proceeds from issuance of common stock  152.9 
Common stock issuance costs  -14.3 
   
Proceeds from issuance of redeemable convertible preferred shares    
Proceeds from issuance of long-term debt   2.0
Debt issuance costs   -0.1
Repayment of long-term debt  -2.0 
    Net cash provided by financing activities  242.219.9
    Net increase in cash and cash equivalents  204.45.8
   
Components of cash, cash equivalents and restricted cash    
Cash and cash equivalents    
Restricted cash    
   
Supplemental cash flow disclosure    
Cash paid for interest  0.10.0
   
Supplemental disclosures of noncash activities    
Conversion of redeemable convertible preferred shares into common stock upon closing of initial public offering  153.3 
Exchange of JDRF note and accrued interest for Series A redeemable convertible preferred shares  1.8 
Purchases of property and equipment included in accounts payable  0.10.1
   
Fair value of warrants to purchase Series A redeemable convertible preferred shares issued to lender    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy